Cite
HARVARD Citation
Avouac, J. et al. (2017). Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension. Annals of the rheumatic diseases. 76 (11), pp. 1931-1940. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Avouac, J. et al. (2017). Pan-PPAR agonist IVA337 is effective in experimental lung fibrosis and pulmonary hypertension. Annals of the rheumatic diseases. 76 (11), pp. 1931-1940. [Online].